Ethical preparedness of data monitoring committees (DMCs) to oversee international clinical trials: a qualitative descriptive study

被引:0
|
作者
Hinga, Alex [1 ]
Ibrahim, Akram [2 ]
Vintimilla, Diego [3 ]
Jones, Mickayla [2 ]
Eckstein, Lisa [4 ]
Rid, Annette [5 ,6 ]
Shah, Seema K. [2 ,7 ]
Kamuya, Dorcas [1 ,8 ]
机构
[1] KEMRI Wellcome Trust Res Programme, Hlth Syst & Res Eth, Nairobi, Kenya
[2] Ann & Robert H Lurie Childrens Hosp Chicago, Stanley Manne Childrens Res Inst, Mary Ann & J Milburn Smith Child Hlth Outcomes Res, Chicago, IL USA
[3] Chicago Dept Publ Hlth, Chicago, IL USA
[4] Univ Tasmania, Sch Law, Hobart, Tas, Australia
[5] NIH, Clin Ctr, Dept Bioeth, Bethesda, MD USA
[6] NIH, Fogarty Int Ctr, Div Int Sci Policy Planning & Evaluat, Bethesda, MD USA
[7] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL USA
[8] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Clin Med, Oxford, England
来源
BMJ GLOBAL HEALTH | 2024年 / 9卷 / 08期
基金
美国国家卫生研究院;
关键词
Global Health; Qualitative study; Clinical trial; Decision Making; Descriptive study; SAFETY; BOARDS; ISSUES;
D O I
10.1136/bmjgh-2024-015233
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction A data monitoring committee (DMC) is an independent group of experts who assess the ongoing scientific and ethical integrity of a study through periodic analyses of study data. The objective of this study was to explore the extent to which the structure, membership and deliberations of DMCs enable them to address ethical issues.Methods We conducted qualitative individual interviews (n=22) with DMC members from countries across Africa, the Americas, South Asia and the UK. We selected interview respondents through purposive sampling, managed data using NVivo (Release V.1.7) and analysed data thematically.Results All respondents were highly experienced professionals; many (18/22) had received training in medicine and/or statistics. One respondent had academic qualifications in ethics, and four indicated that they served on DMCs as ethicists. While respondents generally felt DMCs should be required for studies that were high-risk or enrolled vulnerable populations, some were concerned about the overuse of DMCs. There were divergent views on the necessity of geographical and disciplinary representation in DMC membership, including about whether ethicists were helpful. Many respondents described a DMC member recruitment process that they felt was somewhat exclusive. While one respondent received DMC-specific training, most described learning on the job. Respondents generally agreed that study protocols and DMC charters were key guiding documents for addressing ethical issues and described DMC deliberations that often, but not always, involved consensus-building.Conclusion This study is one of the first to consider the ethical implications of DMC structure, membership and deliberations. The potential overuse of DMCs, DMC member recruitment processes that seem somewhat insular, limited training for DMC members, and divergent approaches to deliberation may limit the capacity of DMCs for addressing ethical issues. Further research on DMC structure and processes could help enhance the ethical preparedness of DMCs.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] “You have to keep your nerve on a DMC.” Challenges for data monitoring committees in neonatal intensive care trials: qualitative accounts from the bracelet study
    Claire Snowdon
    Diana Elbourne
    Peter Brocklehurst
    Martin Ward Platt
    Robert Tasker
    Trials, 16
  • [42] "You have to keep your nerve on a DMC." Challenges for Data Monitoring Committees in neonatal intensive care trials: Qualitative accounts from the BRACELET Study
    Snowdon, Claire
    Brocklehurst, Peter
    Tasker, Robert C.
    Platt, Martin Ward
    Elbourne, Diana
    PLOS ONE, 2018, 13 (07):
  • [43] Health and Ethical Consequences of Outsourcing Pivotal Clinical Trials to Latin America: A Cross-Sectional, Descriptive Study
    Homedes, Nuria
    Ugalde, Antonio
    PLOS ONE, 2016, 11 (06):
  • [44] Proceedings of the University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding Data and Safety Monitoring Committees in clinical trials
    Ellenberg, Susan S.
    Ellenberg, Jonas H.
    CLINICAL TRIALS, 2018, 15 (04) : 319 - 320
  • [45] Nursing student and faculty perceptions of reciprocity during international clinical learning experiences: A qualitative descriptive study
    Gosse, Natalie L.
    Katic-Duffy, Anna
    NURSE EDUCATION TODAY, 2020, 84
  • [46] Data monitoring of clinical trials - An international perspective from the Adjuvant Breast Cancer (ABC) Trial
    Lawrence, D
    Bliss, J
    Yarnold, J
    Johnson, L
    DeCesare, J
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 231S - 231S
  • [47] Experiences and challenges in data monitoring for clinical trials within an international tropical disease research network
    Chen-Mok, M.
    VanRaden, M. J.
    Higgs, E. S.
    Dominik, R.
    CLINICAL TRIALS, 2006, 3 (05) : 469 - 477
  • [48] Response to written feedback of clinical data within a longitudinal study: a qualitative study exploring the ethical implications
    Lorimer, Karen
    Gray, Cindy M.
    Hunt, Kate
    Wyke, Sally
    Anderson, Annie
    Benzeval, Michaela
    BMC MEDICAL RESEARCH METHODOLOGY, 2011, 11
  • [49] Response to written feedback of clinical data within a longitudinal study: a qualitative study exploring the ethical implications
    Karen Lorimer
    Cindy M Gray
    Kate Hunt
    Sally Wyke
    Annie Anderson
    Michaela Benzeval
    BMC Medical Research Methodology, 11
  • [50] Data monitoring committees should be used more frequently and appropriately to monitor paediatric clinical trials, particularly those involving neonates
    Hoppu, Kalle
    ACTA PAEDIATRICA, 2017, 106 (01) : 7 - 8